Answers are grounded in this paper and cite their sources.
A facile strategy affording high-quality single-crystalline MFI-type nanozeolites (10–55 nm) with hexagonal prism morphology, good monodispersity, high crystallinity, and high product yield (above 97%) has been developed. This is achieved by synergistically using an l-lysine-assisted approach and a two-step crystallization process in a concentrated gel system (H2O/Si = 9). The morphological evolution of nanosized silicalite-1 is monitored by high-resolution transmission electron microscopy (HRTEM). In this process, metastable irregular nanoparticles are initially obtained at 80 °C as the first step. Consequently, a rearrangement in morphology toward equilibrium crystal shape and without excessive growth for the metastable nanoparticles occurs at 170 °C as the second step. Throughout the whole process, l-lysine acts as an inhibitor to effectively limit the crystal growth of zeolites. Thanks to the high-quality nanosized crystals, the as-prepared ZSM-5 catalysts exhibit superior performance in methanol-to-propylene (MTP) reactions, which deliver a prolonged lifetime of 54 h with a total light olefin selectivity of 74% and a high propylene selectivity of 49% at 470 °C at a high methanol weight hourly space velocity (WHSV) of 7.2 h–1. This synthetic route provides a general strategy for preparing other types of zeolites with good monodispersity, nanosize, high yield, and high crystallinity.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: